Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Nov;24(5):658–662. doi: 10.1128/aac.24.5.658

Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b.

R S Daum, M P Glode, D Ambrosino, N Halsey, D A Goldmann, F J Mather, R Russell, J Kamon, M Murray, J D Band, et al.
PMCID: PMC185917  PMID: 6607027

Abstract

We compared the effectiveness of rifampin-trimethoprim in fixed combination (3.75:1) to rifampin alone in the eradication of Haemophilus influenzae type b carriage among contacts of patients with invasive infection caused by this organism. The study population was composed of 127 index patients and 620 contacts. Twenty-six percent of contacts were colonized. Rifampin-trimethoprim eradicated carriage in 77.6% of contacts (71.1% in contacts less than 5 years, 84.2% in contacts greater than or equal to 5 years) whereas rifampin eradicated carriage in 69.9% of contacts (56.4% in contacts less than 5 years, 81.8% in contacts greater than or equal to 5 years). A single isolate resistant to rifampin and rifampin-trimethoprim was encountered. The eradication rate achieved with this regimen of rifampin-trimethoprim was too low to recommend its routine use. However, a higher dose or longer course might merit clinical trial.

Full text

PDF
658

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daum R. S., Glode M. P., Goldmann D. A., Halsey N., Ambrosino D., Welborn C., Mather F. J., Willard J. E., Sullivan B., Murray M. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b. J Pediatr. 1981 Mar;98(3):485–491. doi: 10.1016/s0022-3476(81)80731-7. [DOI] [PubMed] [Google Scholar]
  2. Granoff D. M., Daum R. S. Spread of Haemophilus influenzae type b: recent epidemiologic and therapeutic considerations. J Pediatr. 1980 Nov;97(5):854–860. doi: 10.1016/s0022-3476(80)80288-5. [DOI] [PubMed] [Google Scholar]
  3. Jacobson J. A., Fraser D. W. A simplified approach to meningococcal disease prophylaxis. JAMA. 1976 Aug 30;236(9):1053–1054. [PubMed] [Google Scholar]
  4. McDougal L. K., Thornsberry C. In-vitro bactericidal synergism of rifampicin and trimethoprim and implications for treatment of carriers of Haemophilus influenzae. J Antimicrob Chemother. 1982 May;9(5):369–378. doi: 10.1093/jac/9.5.369. [DOI] [PubMed] [Google Scholar]
  5. Mendelman P. M., Roberts M. C., Smith A. L. Mutation frequency of Haemophilus influenzae to rifampin resistance. Antimicrob Agents Chemother. 1982 Sep;22(3):531–533. doi: 10.1128/aac.22.3.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Michaels R. H., Stonebraker F. E., Robbins J. B. Use of antiserum agar for detection of Haemophilus influenzae type b in the pharynx. Pediatr Res. 1975 May;9(5):513–516. doi: 10.1203/00006450-197505000-00010. [DOI] [PubMed] [Google Scholar]
  7. Murphy T. V., McCracken G. H., Jr, Zweighaft T. C., Hansen E. J. Emergence of rifampin-resistant Haemophilus influenzae after prophylaxis. J Pediatr. 1981 Sep;99(3):406–409. doi: 10.1016/s0022-3476(81)80328-9. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES